← Open Payments lookup

KELLY SUCHAR: Open Payments

NPI 1831733252 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$737 in 40 payments from 11 companies in 2025. Trend: 2023 $1,607 · 2024 $315 · 2025 $737

Food & beverage: $737
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.12$189
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$108
Otsuka America Pharmaceutical, Inc.6$107
Vanda Pharmaceuticals Inc.4$100
Neurocrine BioSciences, Inc.4$68
Janssen Pharmaceuticals, Inc3$49
Lundbeck LLC2$41
Sage Therapeutics, LLC1$20
Supernus Pharmaceuticals, Inc.1$19
E.R. Squibb & Sons, L.L.C.1$18

Products named: UZEDY, CAPLYTA, REXULTI, AUSTEDO XR, FANAPT, INGREZZA, ABILIFY MAINTENA, INVEGA SUSTENNA.

Industry payments across PA — which companies pay providers there.